TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 121 filers reported holding TCR2 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $358,000 | -74.1% | 42,084 | -50.0% | 0.01% | -72.2% |
| Q2 2021 | $1,381,000 | -13.8% | 84,167 | +16.0% | 0.02% | -18.2% |
| Q1 2021 | $1,602,000 | -28.6% | 72,534 | 0.0% | 0.02% | -33.3% |
| Q4 2020 | $2,243,000 | +34.8% | 72,534 | -11.4% | 0.03% | +22.2% |
| Q3 2020 | $1,664,000 | +32.3% | 81,909 | 0.0% | 0.03% | +17.4% |
| Q2 2020 | $1,258,000 | +231.9% | 81,909 | +67.2% | 0.02% | +155.6% |
| Q1 2020 | $379,000 | -45.8% | 48,975 | 0.0% | 0.01% | -30.8% |
| Q4 2019 | $699,000 | – | 48,975 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |